New rapid ebola test could speed up outbreak detection

NCT ID NCT07688083

Not yet recruiting Diagnosis Sponsor: Institute of Tropical Medicine, Belgium Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study evaluates a new diagnostic test called DECIPHER bioassay for detecting Ebola virus. Researchers will use stored blood and cheek swab samples from patients in the Democratic Republic of the Congo to see how well the new test compares to the standard lab method. The goal is to determine if this faster, simpler test can accurately identify Ebola infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DECIPHER bioassay (diagnostic test)
What this could lead to: If accurate, this could provide a faster, simpler way to diagnose Ebola in outbreak settings, helping control spread more quickly.
What could go wrong: This is a retrospective study using stored samples, not a real-time outbreak test. The new test may not perform as well in the field as in the lab.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates